Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment
about
P2Y12-ADP receptor antagonists: Days of future and pastCurrent status of high on-treatment platelet reactivity in patients with coronary or peripheral arterial disease: Mechanisms, evaluation and clinical implicationsType 2 Diabetes and ADP Receptor Blocker TherapyComparing the effectiveness and safety between triple antiplatelet therapy and dual antiplatelet therapy in type 2 diabetes mellitus patients after coronary stents implantation: a systematic review and meta-analysis of randomized controlled trialsHigh residual platelet reactivity on clopidogrel: its significance and therapeutic challenges overcoming clopidogrel resistanceLack of association between gene sequence variations of platelet membrane receptors and aspirin responsiveness detected by the PFA-100 system in patients with coronary artery diseaseA review of the mechanisms and effectiveness of dietary polyphenols in reducing oxidative stress and thrombotic riskState-of-the-Art: Hypo-responsiveness to oral antiplatelet therapy in patients with type 2 diabetes mellitus.Mean platelet volume in Type 2 diabetes mellitus.Evaluation of mean platelet volume in patients with type 2 diabetes mellitus and blood glucose regulation: a marker for atherosclerosis?Genotyping of six clopidogrel-metabolizing enzyme polymorphisms has a minor role in the assessment of platelet reactivity in patients with acute coronary syndromeRacial differences in resistance to P2Y12 receptor antagonists in type 2 diabetic subjectsClopidogrel "resistance": where are we now?Anti-platelet drug resistance in the prediction of thromboembolic complications after neurointerventionEffects of cytochrome P450 2C19 and paraoxonase 1 polymorphisms on antiplatelet response to clopidogrel therapy in patients with coronary artery diseaseTicagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial.ABCB1 C3435T polymorphism and response to clopidogrel treatment in coronary artery disease (CAD) patients: a meta-analysisA pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 Trial.Detection of clopidogrel hyporesponsiveness using a point-of-care assay and the impact of additional cilostazol administration after coronary stent implantation in diabetic patients.The effect of clopidogrel on platelet activity in patients with and without type-2 diabetes mellitus: a comparative study.Oral antiplatelet therapy in diabetes mellitus and the role of prasugrel: an overview.Platelet function in patients with diabetes mellitus: from a theoretical to a practical perspectiveEffect of gender difference on platelet reactivity.Pharmacogenomics of cardiovascular complications in diabetes and obesity.Diabetes mellitus and platelet reactivity in patients under prasugrel or ticagrelor treatment: an observational studyIncreased atherothrombotic burden in patients with diabetes mellitus and acute coronary syndrome: a review of antiplatelet therapyClopidogrel resistance response in patients with coronary artery disease and metabolic syndrome: the role of hyperglycemia and obesity.Circulating primers enhance platelet function and induce resistance to antiplatelet therapy.The risk of clopidogrel resistance is associated with ABCB1 polymorphisms but not promoter methylation in a Chinese Han populationClopidogrel resistance is associated with long-term thrombotic events in patients implanted with drug-eluting stents.Association between insulin receptor substrate-1 polymorphisms and high platelet reactivity with clopidogrel therapy in coronary artery disease patients with type 2 diabetes mellitus.Antiplatelet drugs in cardiological practice: established strategies and new developmentsSystematic review and meta-analysis of optimal P2Y12 blockade in dual antiplatelet therapy for patients with diabetes with acute coronary syndromeReduction in recurrent cardiovascular events with prasugrel compared with clopidogrel in patients with acute coronary syndromes from the TRITON-TIMI 38 trialA cardiologist view of vascular disease in diabetes.An Elevated Glycemic Gap is Associated with Adverse Outcomes in Diabetic Patients with Acute Myocardial Infarction.Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with diabetesFactors contributing to increased platelet reactivity in people with diabetesAssociation between increased platelet P-selectin expression and obesity in patients with type 2 diabetes: a BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) substudyDiabetes mellitus: a prothrombotic state implications for outcomes after coronary revascularization
P2860
Q26745619-94EF0E61-2257-47E8-A06E-64BAE92A4102Q26771106-DA2D8864-9014-44C6-8547-248D2A67AD87Q26772996-904DDCD7-DFA4-4869-B128-D42EE64AF952Q26785723-54039C56-A2E4-407C-96F6-67432ECEB962Q26824850-779924FB-44F5-4A58-8542-EA0B15B1254CQ28211198-3480F8E0-AF15-4247-A111-F4515FCD890FQ28301541-62DD327A-7708-4F1A-8473-035F67CA9658Q30373414-F4C6C52C-1394-4CA4-A04F-FA4860D9E6B0Q30420690-88DA514B-BBF0-43A4-9FCA-0E2F5EBBC140Q33756264-E777569B-6356-4D99-A0D6-BF3ECA5CB055Q33792075-BF928235-4635-456C-BC5B-03A819C11D14Q34186272-63A931FB-1343-4873-BA7B-3B5E259C53D1Q34212563-2956A750-0022-433E-8189-B2AEC7F6C899Q34316378-107C5171-8072-41C1-87B8-936DB449C971Q34352152-ECAEE1D5-55CB-474B-B63E-F45E87D1AE94Q34404150-AE390EB3-B72B-407E-A968-952B1C1636A4Q34441355-7FA71CE3-F09D-47B9-B933-CF6F41872166Q34751965-BA547985-7AF0-4F28-B185-9C43425A8EEEQ35033557-DF4EA284-A83A-4A8C-AA3A-F599D1EE9F3EQ35073622-2E1B551D-F998-4DCD-8DB2-0CEB9772D62FQ35141772-F7641543-7321-400E-8FA6-E1F224737016Q35174193-0541F211-0C01-46B6-883A-26D47DD071F6Q35473568-A65E937C-BE68-4264-A8D2-D0326843EA44Q35647167-F3EF12A3-6A47-4D6B-A6F5-469EA094EAB6Q35677083-CA369B84-AA5B-4BBF-9D6D-B6F1A2B8A888Q35755253-B0AB68FC-1E10-4C3D-986F-6FF84EA8F52EQ36011287-DFFC6FC4-E107-42A0-8DAB-6173264D57A4Q36140286-2670C63D-B860-43F0-A981-385E37968B32Q36328226-4877AAF5-EDB1-4C66-9F46-5CDF7D1CD949Q36649824-2DEE7654-4A0B-4522-A994-06B4A9C62073Q36720281-B6C11C71-A158-4137-B30B-B584FC2F3D98Q36835862-5F6C2E6E-A6C7-4391-9DE7-B7DB73BD3986Q36841959-8807FABB-6E26-46F2-A571-C45D786C5EA6Q36935879-5096382F-8FBE-4253-937D-EBF0825ACCB9Q36973815-30A1D63C-2AD8-4475-A8E2-1C0B3560BEF0Q36996153-F0133778-045D-42C6-8779-A792FBC414DDQ37022618-E602C0B2-5FFB-4BF7-BAD1-5ED6DB7E1CD9Q37139534-3392661A-0273-4515-9720-B6D5145D7DBFQ37163821-4732A1AF-E9CE-4AF4-B655-09A0708FA4F4Q37167506-F5927552-E8F0-436D-96FF-99BF6C2E5C5A
P2860
Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment
description
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2005
@ast
im August 2005 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: August 2005)
@en
vedecký článok (publikovaný 2005-08)
@sk
vědecký článek publikovaný v roce 2005
@cs
wetenschappelijk artikel (gepubliceerd in 2005-08)
@nl
наукова стаття, опублікована в серпні 2005
@uk
مقالة علمية (نشرت في أغسطس 2005)
@ar
name
Platelet function profiles in ...... irin and clopidogrel treatment
@ast
Platelet function profiles in ...... irin and clopidogrel treatment
@en
Platelet function profiles in ...... irin and clopidogrel treatment
@nl
type
label
Platelet function profiles in ...... irin and clopidogrel treatment
@ast
Platelet function profiles in ...... irin and clopidogrel treatment
@en
Platelet function profiles in ...... irin and clopidogrel treatment
@nl
prefLabel
Platelet function profiles in ...... irin and clopidogrel treatment
@ast
Platelet function profiles in ...... irin and clopidogrel treatment
@en
Platelet function profiles in ...... irin and clopidogrel treatment
@nl
P2093
P921
P3181
P1433
P1476
Platelet function profiles in ...... irin and clopidogrel treatment
@en
P2093
Camino Bañuelos
Carlos Macaya
Celia Ramírez
Dominick J Angiolillo
Esther Bernardo
Fernando Alfonso
Javier Escaned
Manel Sabaté
Marco A Costa
Pilar Jimenez-Quevedo
P304
P3181
P356
10.2337/DIABETES.54.8.2430
P407
P577
2005-08-01T00:00:00Z